Skip to main content
OpenTrials

Clinical trial condition

Stage IIC Cutaneous Melanoma AJCC v6 and v7

Explore clinical trials studying Stage IIC Cutaneous Melanoma AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIC Cutaneous Melanoma AJCC v6 and v7 trial results

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

NCT01989572

Conditions
Eye Diseases, Eye Neoplasms, Iris Melanoma, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 148 locations
View Trial Details
Completed

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

NCT02129075

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions